Healthconn


Healthconn is a comprehensive health management and medical technology company dedicated to precision medicine, health risk assessment, and personalized health solutions. They focus on integrating advanced diagnostic platforms, molecular biological detection, and AI-driven health prediction to promote overall well-being and disease prevention. With a mission to enhance health through data technology, they aim to be a global leader in health services, offering tailored prevention and management programs for individuals and enterprises.

Industries

biotechnology
health-care
health-diagnostics

Nr. of Employees

small (1-50)

Healthconn

100台北市忠孝東路一段54號5樓


Products

HealthBee app (digital health platform)

Mobile application and digital platform that aggregates personal health records, wearable/device metrics and screening data to provide personalized insights and recommendations.


Services

Provision of molecular and microbiology testing services including cancer gene panels, liquid biopsy assays, multiplex pathogen detection and infectious antigen testing.

Health big-data platform services combining risk assessment, continuous monitoring, remote consultations and personalized health promotion programs.

Design and delivery of tailored employee health-management programs including screening, health promotion and process briefings for employers.

High-volume testing services for environmental and food safety combined with on-site audits, supplier management and risk/quality consulting.

High-touch services for members including appointment coordination, hospital referrals, emergency assistance and follow-up tracking.

Expertise Areas

  • Molecular diagnostics
  • Digital health and health-data analytics
  • Precision medicine and genomics
  • Clinical screening and preventive care
  • Show More (6)

Key Technologies

  • Microfluidics (lab-on-chip)
  • Mass spectrometry
  • Machine learning / AI
  • Next-generation sequencing (cancer genomic profiling)
  • Show More (4)

News & Updates

Research team developed an AI model to predict tuberculosis drug resistance, showcased internationally.

Healthconn participated in a medical industry delegation to Vietnam, engaging with local partners.

A nutritionist discusses seven anti-cancer foods based on statistics showing the importance of diet in cancer prevention.

Research team used spectral analysis and machine learning to develop a real-time prediction model for TB drug resistance.

Healthconn obtained the agency rights for Tempus in Taiwan, modernizing cancer genetic testing with AI technology.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.